Home » Newsletters » BioWorld Asia

BioWorld Asia

July 1, 1998

View Archived Issues

Tm Raises C$14M For Programs Using 'Second Genetic Code'

Cerebrus Forms Joint Venture With Wolfson Institute For CNS

EU Climate Continues To Worsen For Biotech

Sugar-Coated Bioweapon Shows Resilience Of Anthrax

Cambridge Antibody Pays US$11M For Polysome Display Firm

EC Supports US$150M For Biotech Projects

Public Urges French Officials To Monitor Transgenic Plants

Peptech Shares Fluctuate With Veterinary Drug Approval

Enzacta Takes Different Approach To Cancer Chemotherapies

Cerep Licenses Gene Profile System From Xenometrix

Israeli PM Backs Participation In European R&D Program

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...